MedPath

COVID-19 (SARS-CoV-2) in Urine and Semen

Completed
Conditions
Sexual Function and Fertility Disorders
Urine
Urinary Function Disorders
SARS-CoV 2
Semen
Interventions
Diagnostic Test: SARS-CoV 2 RNA PCR Urine
Diagnostic Test: SARS-CoV 2 RNA PCR Semen
Diagnostic Test: Semen Qualitative Analysis
Diagnostic Test: IIEF-5 questionnaire
Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)
Diagnostic Test: IPSS questionnaire
Diagnostic Test: SECRET questionnaire
Diagnostic Test: Interleukin assessment in semen
Registration Number
NCT04446169
Lead Sponsor
University of Florence
Brief Summary

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models.

In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.

Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.

A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.

The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.

Detailed Description

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models.

In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.

Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.

A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer.

According to results obtained, follow up will be tailored to patients (assessment for COVID 19 infections and/or further analysis/folliow-up in case of abnormal findings) The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.

The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
43
Inclusion Criteria
  • Male Sex
  • Age>18 years
  • Will to participate to the study
  • Documented past infection for SARS-CoV2 (Nasopharyngeal swab positive for SARS-CoV2 RNA)
  • Current negative infection for SARS-CoV2 (Two negative Nasopharyngeal swab for SARS-CoV2 RNA, done following WHO guidelines)
Exclusion Criteria
  • Age more than 80 years old
  • Anejaculation
  • Patient's will

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SARS-CoV 2 PatientsSECRET questionnairePatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsInterleukin assessment in semenPatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsSARS-CoV 2 RNA PCR SemenPatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsIPSS questionnairePatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsSemen Qualitative AnalysisPatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsSARS-CoV 2 RNA PCR UrinePatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsIIEF-5 questionnairePatients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
SARS-CoV 2 PatientsMale Sexual Health Questionnaire (MSHQ)Patients with previous nasopharyngeal swab positive for SARS-CoV-2, subsequently negativeized in two detections
Primary Outcome Measures
NameTimeMethod
SARS-CoV 2 presence in semenEnrollment

SARS-CoV 2 RNA PCR in semen

Semen quantitative and qualitative analysisEnrollment

Spermiogram done following WHO guidelines and criteria

SARS-CoV 2 presence in urineEnrollment

SARS-CoV 2 RNA PCR in urine

Inflammation in SemenEnrollment

Interleukin quantitative analysis in Semen, to assess if past inflammation due to SARS-CoV 2 Infection was present

Secondary Outcome Measures
NameTimeMethod
Sexual HabitsEnrollment

SExual Chronicle REcording Table (SECRET) questionnaire administration Questionnaire helps to assess the sexual habits of individuals

Sexual and Ejaculatory FunctionEnrollment

Male Sexual Health Questionnaire Short Form (MSHQ-SF) admnistration Higher scores mean better sexual and ejaculatory function

Urinary functionEnrollment

International Prostate Symptom Score (IPSS) questionnaire administration Score range from 0 to 35. Higher scores mean worst urinary function

Erectile FunctionEnrollment

International Index of Erectile Function (IIEF-5) questionnaire administration. Score range from 0 to 25. Higher scores mean good erectile function

Trial Locations

Locations (1)

AOU Careggi

🇮🇹

Florence, Tuscany, Italy

© Copyright 2025. All Rights Reserved by MedPath